GSWM
BNTX icon

Golden State Wealth Management’s BioNTech BNTX Stock Holding History

Golden State Wealth Management’s Portfolio BNTX Stock Details BNTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10
Closed -$911 – 1577
2025
Q1 		$911 Hold
10
– – ﹤0.01% 1437
2024
Q4 		$1.14K Buy
+10
New +$1.14K ﹤0.01% 1337

Other funds holding BNTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Golden State Wealth Management's BNTX Position: Q2 2025 in Review

Golden State Wealth Management sold out of BioNTech (BNTX) in Q2 2025, closing a stake of 10 shares — an estimated $911 sold.

Golden State Wealth Management first reported a position in BNTX in Q4 2024 and held it in 2 quarters. The position peaked at $1.14K in Q4 2024. 258 funds tracked by Wall St. Rank hold BNTX as of Q2 2025.

  • Golden State Wealth Management reported no remaining BioNTech position as of Q2 2025 after selling out during the quarter.
  • Golden State Wealth Management sold 10 BioNTech shares in Q2 2025, an estimated $911.
  • Golden State Wealth Management first reported a position in BioNTech in Q4 2024 and held it in 2 quarters.
  • Golden State Wealth Management's BioNTech position peaked at $1.14K in Q4 2024.
  • 258 funds tracked by Wall St. Rank held BioNTech as of Q2 2025.

Based on Golden State Wealth Management's 13F filing for Q2 2025, filed 6 Aug 2025.